Lichen International vs Zenta
LICN and ZTG side by side, both in management and public relations services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How LICN and ZTG compare
Zenta keeps more of each dollar of sales as profit, with a net margin of 31.7% compared with −2715% at Lichen International.
Zenta scores higher on the StockData Score (8 against 5 for Lichen International), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | LICN | ZTG |
|---|---|---|
| Size and price | ||
| Share price | $0.040 | $0.427 |
| Change, 1 year | −98.9% | −83.2% |
| Beta (5Y) | – | 5.94 |
| Employees | 399 | 9 |
| StockData Score | ||
| Total score | 5 | 8 (better) |
| Valuation score | 0 | 0 |
| Growth score | 0 | 1 (better) |
| Performance score | 0 | 2 (better) |
| Health score | 5 | 5 |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | – | 55.8% |
| Revenue growth, 5Y average | −51.7% | – |
| Net income growth (TTM) | – | 25.4% |
| EPS growth (TTM) | – | 25.0% |
| Profitability | ||
| Gross margin | 1129% | – |
| Operating margin | −2234% | – |
| Net margin | −2715% | 31.7% (better) |
| FCF margin | −2206% | – |
| Return on equity | −35.1% | 23.4% (better) |
| Return on invested capital | −34.4% | – |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 5.81 | 7.30 (better) |
| Piotroski F-score | 3 | 4 (better) |
| Ownership | ||
| Held by insiders | 0.00% | 64.9% |
| Short interest, % of float | 0.62% | 11.0% |
Go deeper
- LICN stock overview
- LICN income statement
- LICN valuation and score
- ZTG stock overview
- ZTG income statement
- ZTG valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.